Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand
| Autor: | Martin, Eleyna M., Clark, Joanne C., Montague, Samantha J., Morán, Luis A., Di, Ying, Bull, Lily J., Whittle, Luke, Raka, Florije, Buka, Richard J., Zafar, Idrees, Kardeby, Caroline, Slater, Alexandre, Watson, Steve P. |
|---|---|
| Zdroj: | In Journal of Thrombosis and Haemostasis January 2024 22(1):271-285 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|